Clearstead Advisors, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$16,426
+30.4%
300
+100.0%
0.00%
-100.0%
Q2 2023$12,597
+10.9%
1500.0%0.00%0.0%
Q1 2023$11,360
+22.7%
1500.0%0.00%0.0%
Q4 2022$9,258
+54.3%
1500.0%0.00%0.0%
Q3 2022$6,000
+20.0%
1500.0%0.00%
Q2 2022$5,000
+25.0%
1500.0%0.00%
Q1 2022$4,000
+33.3%
1500.0%0.00%
Q4 2021$3,000
-40.0%
1500.0%0.00%
Q3 2021$5,0000.0%1500.0%0.00%
Q2 2021$5,000
-16.7%
1500.0%0.00%
Q1 2021$6,0001500.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders